Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia

L. Stewart Massad, Xianhong Xie, Ruth M. Greenblatt, Howard Minkoff, Lorraine Sanchez-Keeland, D. Heather Watts, Rodney L. Wright, Gypsyamber D'Souza, Daniel Merenstein, Howard Strickler

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: To estimate the prevalence, incidence, and clearance of abnormal vaginal cytology and vaginal intraepithelial neoplasia (VAIN) in human immunodeficiency virus (HIV)-seropositive women. METHODS: Pap tests were done semiannually for 335 HIV-seropositive and 75 HIV-seronegative women with prior hysterectomy in the prospective Women's Interagency HIV Study cohort. End points included abnormal Pap test results after hysterectomy and VAIN regardless of hysterectomy. RESULTS: Over a median of 5.6 years of follow-up, vaginal Pap test results were abnormal at 1,076 (29%; 95% confidence interval [CI] 25-33%) of 3,700 visits among HIV-seropositive compared with 31 (4%; 95% CI 2-8%) of 763 visits among HIV-seronegative women (P<.001). Abnormal Pap test results included 641 atypical squamous cells of undetermined significance, 425 low-grade squamous intraepithelial lesions, and 10 high-grade squamous intraepithelial lesions in HIV-seropositive women and 28 atypical squamous cells of undetermined significance and three low-grade squamous intraepithelial lesions in HIV-seronegative women. The incidence of abnormal Pap test results after hysterectomy was 14 per 100 person-years among HIV-seropositive and two per 100 person-years among HIV-seronegative women (P<.001) and remained stable across time. The 5-year clearance rate of abnormal Pap test results was 34 per 100 person-years for HIV-seropositive and 116 per 100 person-years for HIV-seronegative women (P<.001). In multivariate regression models, women with lower CD4 counts were more likely to have and less likely to clear abnormal cytology when it occurred. The incidence of VAIN 2 or worse was 0.2 and 0.01 per 100 person-years for HIV-seropositive and HIV-seronegative women (P=.001). Two HIV-seropositive women developed stage II cancers with remission after radiotherapy. CONCLUSION: Vaginal Pap test results are often abnormal in HIV-seropositive women. Although more common than in HIV-seronegative women, VAIN 2 or worse and especially vaginal cancers are infrequent.

Original languageEnglish (US)
Pages (from-to)582-589
Number of pages8
JournalObstetrics and Gynecology
Volume119
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Virus Diseases
HIV
Incidence
Papanicolaou Test
Neoplasms
Hysterectomy
Cell Biology
Vaginal Neoplasms
Confidence Intervals
Vaginal Hysterectomy
CD4 Lymphocyte Count

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia. / Massad, L. Stewart; Xie, Xianhong; Greenblatt, Ruth M.; Minkoff, Howard; Sanchez-Keeland, Lorraine; Watts, D. Heather; Wright, Rodney L.; D'Souza, Gypsyamber; Merenstein, Daniel; Strickler, Howard.

In: Obstetrics and Gynecology, Vol. 119, No. 3, 03.2012, p. 582-589.

Research output: Contribution to journalArticle

Massad, L. Stewart ; Xie, Xianhong ; Greenblatt, Ruth M. ; Minkoff, Howard ; Sanchez-Keeland, Lorraine ; Watts, D. Heather ; Wright, Rodney L. ; D'Souza, Gypsyamber ; Merenstein, Daniel ; Strickler, Howard. / Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia. In: Obstetrics and Gynecology. 2012 ; Vol. 119, No. 3. pp. 582-589.
@article{93bf93b0f8f84536890fb6fc41902194,
title = "Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia",
abstract = "OBJECTIVE: To estimate the prevalence, incidence, and clearance of abnormal vaginal cytology and vaginal intraepithelial neoplasia (VAIN) in human immunodeficiency virus (HIV)-seropositive women. METHODS: Pap tests were done semiannually for 335 HIV-seropositive and 75 HIV-seronegative women with prior hysterectomy in the prospective Women's Interagency HIV Study cohort. End points included abnormal Pap test results after hysterectomy and VAIN regardless of hysterectomy. RESULTS: Over a median of 5.6 years of follow-up, vaginal Pap test results were abnormal at 1,076 (29{\%}; 95{\%} confidence interval [CI] 25-33{\%}) of 3,700 visits among HIV-seropositive compared with 31 (4{\%}; 95{\%} CI 2-8{\%}) of 763 visits among HIV-seronegative women (P<.001). Abnormal Pap test results included 641 atypical squamous cells of undetermined significance, 425 low-grade squamous intraepithelial lesions, and 10 high-grade squamous intraepithelial lesions in HIV-seropositive women and 28 atypical squamous cells of undetermined significance and three low-grade squamous intraepithelial lesions in HIV-seronegative women. The incidence of abnormal Pap test results after hysterectomy was 14 per 100 person-years among HIV-seropositive and two per 100 person-years among HIV-seronegative women (P<.001) and remained stable across time. The 5-year clearance rate of abnormal Pap test results was 34 per 100 person-years for HIV-seropositive and 116 per 100 person-years for HIV-seronegative women (P<.001). In multivariate regression models, women with lower CD4 counts were more likely to have and less likely to clear abnormal cytology when it occurred. The incidence of VAIN 2 or worse was 0.2 and 0.01 per 100 person-years for HIV-seropositive and HIV-seronegative women (P=.001). Two HIV-seropositive women developed stage II cancers with remission after radiotherapy. CONCLUSION: Vaginal Pap test results are often abnormal in HIV-seropositive women. Although more common than in HIV-seronegative women, VAIN 2 or worse and especially vaginal cancers are infrequent.",
author = "Massad, {L. Stewart} and Xianhong Xie and Greenblatt, {Ruth M.} and Howard Minkoff and Lorraine Sanchez-Keeland and Watts, {D. Heather} and Wright, {Rodney L.} and Gypsyamber D'Souza and Daniel Merenstein and Howard Strickler",
year = "2012",
month = "3",
doi = "10.1097/AOG.0b013e318244ee3d",
language = "English (US)",
volume = "119",
pages = "582--589",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of human immunodeficiency virus infection on the prevalence and incidence of vaginal intraepithelial neoplasia

AU - Massad, L. Stewart

AU - Xie, Xianhong

AU - Greenblatt, Ruth M.

AU - Minkoff, Howard

AU - Sanchez-Keeland, Lorraine

AU - Watts, D. Heather

AU - Wright, Rodney L.

AU - D'Souza, Gypsyamber

AU - Merenstein, Daniel

AU - Strickler, Howard

PY - 2012/3

Y1 - 2012/3

N2 - OBJECTIVE: To estimate the prevalence, incidence, and clearance of abnormal vaginal cytology and vaginal intraepithelial neoplasia (VAIN) in human immunodeficiency virus (HIV)-seropositive women. METHODS: Pap tests were done semiannually for 335 HIV-seropositive and 75 HIV-seronegative women with prior hysterectomy in the prospective Women's Interagency HIV Study cohort. End points included abnormal Pap test results after hysterectomy and VAIN regardless of hysterectomy. RESULTS: Over a median of 5.6 years of follow-up, vaginal Pap test results were abnormal at 1,076 (29%; 95% confidence interval [CI] 25-33%) of 3,700 visits among HIV-seropositive compared with 31 (4%; 95% CI 2-8%) of 763 visits among HIV-seronegative women (P<.001). Abnormal Pap test results included 641 atypical squamous cells of undetermined significance, 425 low-grade squamous intraepithelial lesions, and 10 high-grade squamous intraepithelial lesions in HIV-seropositive women and 28 atypical squamous cells of undetermined significance and three low-grade squamous intraepithelial lesions in HIV-seronegative women. The incidence of abnormal Pap test results after hysterectomy was 14 per 100 person-years among HIV-seropositive and two per 100 person-years among HIV-seronegative women (P<.001) and remained stable across time. The 5-year clearance rate of abnormal Pap test results was 34 per 100 person-years for HIV-seropositive and 116 per 100 person-years for HIV-seronegative women (P<.001). In multivariate regression models, women with lower CD4 counts were more likely to have and less likely to clear abnormal cytology when it occurred. The incidence of VAIN 2 or worse was 0.2 and 0.01 per 100 person-years for HIV-seropositive and HIV-seronegative women (P=.001). Two HIV-seropositive women developed stage II cancers with remission after radiotherapy. CONCLUSION: Vaginal Pap test results are often abnormal in HIV-seropositive women. Although more common than in HIV-seronegative women, VAIN 2 or worse and especially vaginal cancers are infrequent.

AB - OBJECTIVE: To estimate the prevalence, incidence, and clearance of abnormal vaginal cytology and vaginal intraepithelial neoplasia (VAIN) in human immunodeficiency virus (HIV)-seropositive women. METHODS: Pap tests were done semiannually for 335 HIV-seropositive and 75 HIV-seronegative women with prior hysterectomy in the prospective Women's Interagency HIV Study cohort. End points included abnormal Pap test results after hysterectomy and VAIN regardless of hysterectomy. RESULTS: Over a median of 5.6 years of follow-up, vaginal Pap test results were abnormal at 1,076 (29%; 95% confidence interval [CI] 25-33%) of 3,700 visits among HIV-seropositive compared with 31 (4%; 95% CI 2-8%) of 763 visits among HIV-seronegative women (P<.001). Abnormal Pap test results included 641 atypical squamous cells of undetermined significance, 425 low-grade squamous intraepithelial lesions, and 10 high-grade squamous intraepithelial lesions in HIV-seropositive women and 28 atypical squamous cells of undetermined significance and three low-grade squamous intraepithelial lesions in HIV-seronegative women. The incidence of abnormal Pap test results after hysterectomy was 14 per 100 person-years among HIV-seropositive and two per 100 person-years among HIV-seronegative women (P<.001) and remained stable across time. The 5-year clearance rate of abnormal Pap test results was 34 per 100 person-years for HIV-seropositive and 116 per 100 person-years for HIV-seronegative women (P<.001). In multivariate regression models, women with lower CD4 counts were more likely to have and less likely to clear abnormal cytology when it occurred. The incidence of VAIN 2 or worse was 0.2 and 0.01 per 100 person-years for HIV-seropositive and HIV-seronegative women (P=.001). Two HIV-seropositive women developed stage II cancers with remission after radiotherapy. CONCLUSION: Vaginal Pap test results are often abnormal in HIV-seropositive women. Although more common than in HIV-seronegative women, VAIN 2 or worse and especially vaginal cancers are infrequent.

UR - http://www.scopus.com/inward/record.url?scp=84859088957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859088957&partnerID=8YFLogxK

U2 - 10.1097/AOG.0b013e318244ee3d

DO - 10.1097/AOG.0b013e318244ee3d

M3 - Article

C2 - 22353957

AN - SCOPUS:84859088957

VL - 119

SP - 582

EP - 589

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -